In Bedrocan Series, hear from the real experts in the medical cannabis field, learn about uses, and gain understanding into the latest scientific studies and insights. Through a free online meeting, we connect you with doctors, researchers and scientists who have extensive experience with medicinal cannabis. In just half an hour, we can bring you up to speed.
Below you will find an overview of the speakers on the program. The language of instruction is English.
The development of new medicines based on the effect of cannabis on our brain
With Dr. Mario van der Stelt
On Wednesday, 18 May, Prof. Dr Mario van der Stelt was our guest in Bedrocan Series. Van der Stelt is chairman and professor of Molecular Physiology at the Leiden Institute of Chemistry. In this Webinar, Van der Stelt explains how cannabis is used as inspiration for the further development of medicines. Van der Stelt’s main motivation is to understand how our brains function and use this to develop medicines for MS and chronic pain.
Curious? Click on the button below and watch the replay.
Tics, nabiximols and more
With Dr. Kirsten R. Müller-Vahl
On Thursday, 28 April, Prof. Dr. Kirsten R. Müller-Vahl was a guest in the webinar of the Bedrocan Series. Müller-Vahl is a Professor of Psychiatry in the Department of Psychiatry, Social Psychiatry and Psychotherapy at the Hanover Medical School in Germany. Müller-Vahl has been researching the effect of medicinal cannabis in the treatment of tics and other psychiatric disorders for more than twenty years. In this webinar, Müller-Vahl shares the the most recent CANNA-TICS study results in which the effect of nabiximol was investigated in Gilles de la Tourette patients. She will also speak first-hand about an unpublished study on the use of cannabis among German patients.
Curious to learn more? Watch the replay.
Outpatient clinic for medicinal cannabis and psychiatry
With Dr. Albert Batalla
Dr. Albert Batalla, psychiatrist and researcher at the University Medical Center Utrecht, recently opened an outpatient clinic for medicinal cannabis and psychiatry. This is the only clinic of this kind in the Netherlands. During this webinar Batalla shares his motivation for opening the outpatient clinic, his experience as a psychiatrist with prescribing medicinal cannabis for mental illness, the risks and side effects of its use and why medicinal cannabis should only be used under a doctor’s supervision.
Curious to hear more? Watch the replay by pressing on the button below.
Cannabis labelling is driven by heritable terpene profiles
With Sophie Watts
Sophie Watts researched the way cannabis is labelled at Dalhousie’s Faculty of Agriculture. Her research is recently featured in Nature Plants and shows that the current labelling of ‘Indica’ and ‘Sativa’ is misleading.
Curious to hear more about this topic? Watch the full webinar by pressing on the button below.
Towards precise medicinal cannabis treatment
With Perry Davidson
Learn from Syqe’s CEO Perry Davidson how he developed a drug delivery technology that allows doctors to treat patients with medicinal cannabis with a high precision. He explains the impact of a precise cannabis treatment and talks you through Syqe’s randomised placebo-controlled clinical trial.
Cannabis as a medicine, chronic pain and opiates
With Monique van Velzen
Monique van Velzen is research manager, assistant professor and supervisor of medical researchers at the Anesthesiology department of the LUMC in Leiden, Netherlands. Her research focuses on understanding patients with (chronic) pain better and studying the most optimal form of pain relief. Since 2017, Monique has been supervising research into medicinal cannabis for specific types of pain.
Cannabis as a medicine, the effects on our brain
With Matthijs Bossong
Matthijs Bossong studied Biomedical Sciences at Utrecht University, the Netherlands. After completing his PhD in Utrecht on the role of the endocannabinoid system in human brain functions relevant for psychiatric disorders, he started his postdoc position at the Institute of Psychiatry of King’s College London. Here, Matthijs worked on two multimodal neuroimaging studies with people at an ultra-high risk for developing psychosis. One of these projects involved a treatment with the cannabinoid compound cannabidiol. Now Matthijs works at the University Medical Center Utrecht.
Cannabis as a medicine, the scientific approach
With Renger Witkamp
With a background in Biology and Pharmacy Renger works as a professor at Wageningen University & Research, Netherlands, where he currently leads the Nutritional Biology group. Renger has diverse experience both scientific and in management positions. Since 2005 Renger has been involved the field of cannabis research and the functioning of the endocannabinoid system. In addition to his role in education and research he is the chairman of the Institute Medicinal Cannabis Netherlands.